Table 1.

Ongoing and currently recruiting clinical trials involving CAR T-cell therapies for solid tumors (22).

Intervention	Condition	Location	ClinicalTrials.gov Identifier
CEA CAR T-cells	Pancreatic Cancer	Chongqing University Cancer Hospital Chongqing, Chongqing, China	NCT04348643
CD276 CAR T-cells	Advanced Pancreatic Cancer	Li Yu Shenzhen, Guangdong, China	NCT05143151
CT041 autologous CAR T-cell	Pancreatic Cancer	Anhui Provincial Cancer Hospital Hefei, Anhui, China	NCT04581473
BPX-601 CAR T-cells	Metastatic Castration-resistant Prostate Cancer, Metastatic Prostate Cancer, Metastatic Pancreatic Ductal Adenocarcinoma, Metastatic Pancreatic Cancer and Metastatic Pancreatic Adenocarcinoma	Moffitt Cancer Center Tampa, FL, USA	NCT02744287
Anti-hCD70 CAR transduced PBL	Pancreatic Cancer	National Institutes of Health Clinical Center Bethesda, MD, USA	NCT02830724
CEA CAR T-cells	Breast Cancer	Chongqing University Cancer Hospital Chongqing, Chongqing, China	NCT04348643
4S CAR T-cells	Breast Cancer	The Seventh Affiliated Hospital, Sun Yat-Sen University Shenzhen, Guangdong, China	NCT04430595
CD44v6-specific CAR T-cells	Cancers Which Are CD44v6 Positive	Shenzhen Children’s Hospital, Shenzhen, Guangdong, China	NCT04427449
Anti-hCD70 CAR transduced PBL	Breast Cancer	National Institutes of Health Clinical Center, Bethesda, MD, USA	NCT02830724
AIC100 CAR T-cells	Anaplastic Thyroid Cancer and Relapsed/Refractory Poorly Differentiated Thyroid Cancer	Weill Cornell Medical College New York, NY, USA	NCT04420754
single dose of CAR T-GFRa4 cells	Metastatic Medullary Thyroid Cancer	University of Pennsylvania Philadelphia, PA, USA	NCT04877613
EGFRv III -CAR transduced PBL	Malignant Glioma	National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, MD, USA	NCT01454596
anti-CD133-CAR vector-transduced T cells	Brain Tumor	Biotherapeutic, Department and Pediatrics Department of Chinese PLA General Hospital Beijing, Beijing, China	NCT02541370